RIPA-56   Click here for help

GtoPdb Ligand ID: 9643

Synonyms: compound 56 [PMID: 27992216] | compound 92 [WO2016101885]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: RIPA-56 is a highly potent, selective, and metabolically stable type III (allosteric) inhibitor of receptor-interacting protein kinase 1 (RIPK1) [2]. It is claimed as compound 92 in patent WO2016101885 [3]. RIPA-56 is a drug candidate for the treatment of systemic inflammatory response syndrome (SIRS).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 40.54
Molecular weight 221.14
XLogP 2.19
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(C(=O)N(Cc1ccccc1)O)(C)C
Isomeric SMILES CCC(C(=O)N(Cc1ccccc1)O)(C)C
InChI InChI=1S/C13H19NO2/c1-4-13(2,3)12(15)14(16)10-11-8-6-5-7-9-11/h5-9,16H,4,10H2,1-3H3
InChI Key AVYVHIKSFXVDBG-UHFFFAOYSA-N
Bioactivity Comments
RIPA-56 is active against human and mouse RIPK1 and is efficacious in animal models [2]. It is devoid of off-target IDO inhibiting activity.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
receptor interacting serine/threonine kinase 1 Primary target of this compound Hs Inhibitor Inhibition 7.9 pIC50 - 2
pIC50 7.9 (IC50 1.3x10-8 M) [2]
Description: Inhibition of RIPK1 enzymatic activity in vitro.